Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 134,986 251,929 319,053 656,089
Total Sell Value $11,097,511 $21,508,551 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 9 19 27 56
End Date 2024-04-07 2024-01-05 2023-07-07 2022-07-07

   
Records found: 1285
  Page 47 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Baffi Robert EVP, Technical Operations   •       –      –    2015-05-19 4 GA $0.00 $0 I/I 1,434 27,670     -
   Baffi Robert EVP, Technical Operations   •       –      –    2015-05-19 4 GD $0.00 $0 D/D 1,434 102,700     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2015-05-18 4 AS $130.00 $4,430,140 D/D (34,078) 41,507     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2015-05-18 4 S $124.77 $256,905 D/D (2,059) 75,585     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2015-05-18 4 AS $124.78 $232,584 D/D (1,864) 76,746     -
   Davis George Eric SVP, General Counsel   •       –      –    2015-05-18 4 S $125.26 $320,415 D/D (2,558) 69,226     -
   Mueller Brian VP, Corporate Controller   •       –      –    2015-05-15 4 D $122.78 $25,415 D/D (207) 12,756     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2015-05-15 4 D $122.78 $211,427 D/D (1,722) 77,644     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2015-05-15 4 D $122.78 $249,980 D/D (2,036) 78,610     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-05-15 4 D $122.78 $605,551 D/D (4,932) 235,894     -
   Davis George Eric SVP, General Counsel   •       –      –    2015-05-15 4 D $122.78 $134,567 D/D (1,096) 71,784     -
   Baffi Robert EVP, Technical Operations   •       –      –    2015-05-15 4 D $122.78 $192,273 D/D (1,566) 104,134     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2015-05-15 4 D $122.78 $134,567 D/D (1,096) 40,870     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2015-05-13 4 AS $121.37 $174,038 D/D (1,434) 80,646     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-05-12 4 D $121.09 $284,440 D/D (2,349) 240,826     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2015-05-12 4 D $121.09 $189,627 D/D (1,566) 82,080     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2015-05-11 4 AS $121.64 $348,988 D/D (2,869) 83,646     -
   Mueller Brian VP, Corporate Controller   •       –      –    2015-05-08 4 D $121.66 $54,017 D/D (444) 12,963     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2015-05-08 4 D $121.66 $380,917 D/D (3,131) 86,515     -
   Davis George Eric SVP, General Counsel   •       –      –    2015-05-08 4 D $121.66 $206,335 D/D (1,696) 72,880     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2015-05-08 4 D $121.66 $666,575 D/D (5,479) 243,175     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2015-05-08 4 D $121.66 $82,607 D/D (679) 41,966     -
   Baffi Robert EVP, Technical Operations   •       –      –    2015-05-08 4 A $121.66 $254,026 D/D 2,088 105,700     -
   Baffi Robert EVP, Technical Operations   •       –      –    2015-05-08 4 GA $0.00 $0 I/I 1,912 26,236     -
   Baffi Robert EVP, Technical Operations   •       –      –    2015-05-08 4 GD $0.00 $0 D/D 1,912 107,788     -
  1285 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 47 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us